Enteric Softgel Capsules Market Size, Share | Forecast By 2032

IMARC Group's report titled "Enteric Softgel Capsules Market Report by Type (Gelatin Capsules, Non-Gelatin Softgel Capsules), Application (Health Supplements, Pharmaceuticals), Distribution Channel (Supermarkets and Hypermarkets, Pharmacy and Drug Stores, Online Stores), and Region 2024-2032". The global enteric softgel capsules market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/enteric-softgel-capsules-market/requestsample

Factors Affecting the Growth of the Enteric Softgel Capsules Industry:

• Rising Prevalence of Gastrointestinal Disorders:

The increasing occurrence of various gastrointestinal diseases, such as irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux disease, is impelling the growth of the market. These capsules are designed to bypass the stomach and dissolve in the intestine, where they can deliver medication more effectively to the site of absorption. This targeted delivery system minimizes gastric irritation and enhances therapeutic efficacy, making enteric softgel capsules a preferred choice for medications affecting the gastrointestinal tract.

• Technological Advancements in Capsule Manufacturing:

Modern technologies enable the production of highly sophisticated capsules with improved enteric coating techniques that ensure the precise release of active ingredients at the desired intestinal site. These advancements are leading to the development of capsules that are more resistant to the acidic environment of the stomach, thereby enhancing the bioavailability of the medication. Furthermore, innovations in capsule material are also contributing to the production of vegan and vegetarian-friendly. The continuous improvement in manufacturing processes and materials not only enhances product quality but also reduces production costs, making enteric softgel capsules more accessible to a wider audience.

• Growing Focus on Personalized Medicine:

The shift towards personalized medicine and patient-centric treatment approaches is supporting the market growth. Personalized medicine emphasizes the customization of healthcare, with medical decisions, practices, and/or products being tailored to the individual patient. Enteric softgel capsules play a crucial role in this paradigm shift by enabling the precise delivery of drugs based on the specific needs of patients, such as targeting the release of medication to certain parts of the intestine for optimized absorption and effectiveness. Additionally, the ability to incorporate various active ingredients into a single capsule can facilitate the administration of combination therapies, further aligning with the principles of personalized medicine.

Leading Companies Operating in the Global Enteric Softgel Capsules Industry:

• Aenova Group GmbH
• BASF SE
• Catalent, Inc.
• Colorcon Inc.
• Fuji Capsule Co., Ltd.
• Lonza Group AG
• Now Health Group, Inc.
• ProCaps Group
• Super Spectrim
• Thermo Fisher Scientific, Inc

Enteric Softgel Capsules Market Report Segmentation:

By Type:

• Gelatin Capsules
• Non-Gelatin Softgel Capsules

Gelatin capsules represent the largest segment as they can be easily consumed and offer spontaneous absorption.

By Application:

• Health Supplements
• Pharmaceuticals

Health supplements exhibit a clear dominance in the market due to the rising health awareness among the masses.

By Distribution Channel:

• Supermarkets and Hypermarkets
• Pharmacy and Drug Stores
• Online Stores

Pharmacy and drug stores represent the leading segment. They offer an extensive range of enteric softgel capsules for a reasonable price range.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in the enteric softgel capsules market is attributed to investment in drug research, leading to the development of advanced medications.

Global Enteric Softgel Capsules Market Trends:

The stringent regulatory environment surrounding pharmaceutical manufacturing is bolstering the market growth. Regulatory agencies are establishing specific guidelines and standards for the production of enteric-coated products to ensure their safety, efficacy, and quality. Compliance with these regulations encourages manufacturers to invest in research and development (R&D) to innovate and improve enteric softgel capsules. This includes advancements in enteric coating materials that are safe for consumption and effective in protecting the contents of the capsule from the acidic pH of the stomach. The regulatory emphasis on patient safety and product quality reassures healthcare professionals and patients about the reliability of enteric softgel capsules, thereby fostering trust.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163